By Elena Rocca
Pharmacology is a complex science that aims to balance harm and benefit of treatments for the individual patient. How should different types of evidence be synthesised in order to optimize this task? Should evidence from randomized trials be prioritized over other evidence, following the EBM model? If not, how can different types of evidence be amalgamated in an alternative way?
These questions were discussed at the workshop Drug Safety, Probabilistic Causal Assessment, and Evidence Synthesis, organized on 27-28 January at the Ludwig-Maximilians University in Munich by the project Philosophy of Pharmacology.
The CauseHealth team contributed with two talks aimed to suggest how a dispositionalist account of causation can contribute to understanding the concept of mechanism in medicine and the synthesis of evidence.
You can find a detailed report of this exciting event at the PhilPharma project website: